- Home
- IMAB vs ALTS Comparison
IMAB vs ALTS Comparison
Compare IMAB & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- ALTS
- Stock Information
- Founded
- IMAB 2014
- ALTS 1976
- Country
- IMAB United States
- ALTS United States
- Employees
- IMAB N/A
- ALTS N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- IMAB Health Care
- ALTS
- Exchange
- IMAB Nasdaq
- ALTS NYSE
- Market Cap
- IMAB 200.9M
- ALTS 159.4M
- IPO Year
- IMAB 2020
- ALTS N/A
- Fundamental
- Price
- IMAB $2.15
- ALTS $7.85
- Analyst Decision
- IMAB Strong Buy
- ALTS
- Analyst Count
- IMAB 2
- ALTS 0
- Target Price
- IMAB $6.00
- ALTS N/A
- AVG Volume (30 Days)
- IMAB 982.8K
- ALTS 298.8K
- Earning Date
- IMAB 05-15-2025
- ALTS 08-18-2025
- Dividend Yield
- IMAB N/A
- ALTS N/A
- EPS Growth
- IMAB N/A
- ALTS N/A
- EPS
- IMAB N/A
- ALTS N/A
- Revenue
- IMAB N/A
- ALTS $18,046,000.00
- Revenue This Year
- IMAB N/A
- ALTS $185.91
- Revenue Next Year
- IMAB N/A
- ALTS $64.93
- P/E Ratio
- IMAB N/A
- ALTS N/A
- Revenue Growth
- IMAB N/A
- ALTS N/A
- 52 Week Low
- IMAB $0.60
- ALTS $1.29
- 52 Week High
- IMAB $3.08
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- IMAB 50.70
- ALTS 46.63
- Support Level
- IMAB $2.00
- ALTS $6.62
- Resistance Level
- IMAB $2.95
- ALTS $8.14
- Average True Range (ATR)
- IMAB 0.34
- ALTS 1.01
- MACD
- IMAB -0.08
- ALTS -0.30
- Stochastic Oscillator
- IMAB 15.79
- ALTS 34.68
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.